Epstein–Barr virus reactivation in extranodal natural killer/T-cell lymphoma patients: a previously unrecognized serious adverse event in a pilot study with romidepsinSeung Ju Kim, Woo Seob Kim, Young Hyeh Ko et al.|Annals of Oncology|2015Cited by 69
A phase II study of everolimus (RAD001), an mTOR inhibitor plus CHOP for newly diagnosed peripheral T-cell lymphomasSeung Ju Kim, Woo Seob Kim, Dong-Yeop Shin et al.|Annals of Oncology|2016Cited by 54
Combination treatment of copanlisib and gemcitabine in relapsed/refractory PTCL (COSMOS): an open-label phase I/II trialHo‐Young Yhim, Deok‐Hwan Yang, T. Kim et al.|Annals of Oncology|2020Cited by 27